Search research articles
Contact Us
Filters
Showing results (1-10 of 267) with videos related to
Page
of 27
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 11, 2019
Reply to Jain et al
Farnaz Foolad, Roy F Chemaly
Expert Review of Clinical Pharmacology
|
July 14, 2018
Letermovir for the prevention of cytomegalovirus infection in adult cytomegalovirus-seropositive hematopoietic stem cell transplant recipients
Farnaz Foolad, Samuel L Aitken, Roy F Chemaly
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 12, 2018
Oral Versus Aerosolized Ribavirin for the Treatment of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant Recipients
Farnaz Foolad, Samuel L Aitken, Terri Lynn Shigle, et al.
The Journal of Antimicrobial Chemotherapy
|
November 10, 2017
Persistent CNS toxicity in a patient receiving posaconazole tablets after discontinuation of voriconazole due to supratherapeutic serum levels
Farnaz Foolad, Dimitrios P Kontoyiannis
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
July 13, 2021
The ever-growing world of infections in immunocompromised patients: major headways with numerous shortcomings
Roy F Chemaly
Cancer Letters
|
March 1, 2011
ZnT2-overexpression represses the cytotoxic effects of zinc hyper-accumulation in malignant metallothionein-null T47D breast tumor cells
Veronica Lopez, Farnaz Foolad, Shannon L Kelleher
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 8, 2021
Refractory and Resistant Cytomegalovirus After Hematopoietic Cell Transplant in the Letermovir Primary Prophylaxis Era
Joseph Sassine, Fareed Khawaja, Terri Lynn Shigle, et al.
Haematologica
|
June 22, 2019
Respiratory syncytial virus in hematopoietic cell transplant recipients and patients with hematologic malignancies
Fareed Khawaja, Roy F Chemaly
Expert Opinion on Biological Therapy
|
December 10, 2008
Palivizumab: where to from here?
Georgiana Georgescu, Roy F Chemaly
Bone Marrow Transplantation
|
February 27, 2022
Predicting risk of progression to lower respiratory tract infection in allogeneic hematopoietic cell transplant recipients with respiratory viral infections: where are we now?
Fareed Khawaja, Roy F Chemaly
Page
of 27
Search research articles
Search
Showing results (1-10 of 267) with videos related to
Sort By:
Page
of 27
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 11, 2019
Reply to Jain et al
Farnaz Foolad, Roy F Chemaly
Expert Review of Clinical Pharmacology
|
July 14, 2018
Letermovir for the prevention of cytomegalovirus infection in adult cytomegalovirus-seropositive hematopoietic stem cell transplant recipients
Farnaz Foolad, Samuel L Aitken, Roy F Chemaly
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 12, 2018
Oral Versus Aerosolized Ribavirin for the Treatment of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant Recipients
Farnaz Foolad, Samuel L Aitken, Terri Lynn Shigle, et al.
The Journal of Antimicrobial Chemotherapy
|
November 10, 2017
Persistent CNS toxicity in a patient receiving posaconazole tablets after discontinuation of voriconazole due to supratherapeutic serum levels
Farnaz Foolad, Dimitrios P Kontoyiannis
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
July 13, 2021
The ever-growing world of infections in immunocompromised patients: major headways with numerous shortcomings
Roy F Chemaly
Cancer Letters
|
March 1, 2011
ZnT2-overexpression represses the cytotoxic effects of zinc hyper-accumulation in malignant metallothionein-null T47D breast tumor cells
Veronica Lopez, Farnaz Foolad, Shannon L Kelleher
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 8, 2021
Refractory and Resistant Cytomegalovirus After Hematopoietic Cell Transplant in the Letermovir Primary Prophylaxis Era
Joseph Sassine, Fareed Khawaja, Terri Lynn Shigle, et al.
Haematologica
|
June 22, 2019
Respiratory syncytial virus in hematopoietic cell transplant recipients and patients with hematologic malignancies
Fareed Khawaja, Roy F Chemaly
Expert Opinion on Biological Therapy
|
December 10, 2008
Palivizumab: where to from here?
Georgiana Georgescu, Roy F Chemaly
Bone Marrow Transplantation
|
February 27, 2022
Predicting risk of progression to lower respiratory tract infection in allogeneic hematopoietic cell transplant recipients with respiratory viral infections: where are we now?
Fareed Khawaja, Roy F Chemaly
Page
of 27